AVANOS MEDICAL, INC. Long-Term Debt

Quick Answer

AVANOS MEDICAL, INC. reported Long-Term Debt of $90.30 million for fiscal year 2025.

AVANOS MEDICAL, INC. Long-Term Debt — Annual History

Fiscal Year Long-Term Debt YoY Change
2025 $90.30M -27.9%
2024 $125.30M -21.4%
2023 $159.40M -29.6%
2022 $226.30M +74.1%
2021 $130.00M -27.8%
2020 $180.00M -27.4%
2019 $248.10M +0.2%
2018 $247.70M -54.2%
2017 $541.10M -6.5%
2016 $579.00M +0.2%
2015 $578.10M -7.1%
2014 $622.60M
2013 $0.00

Quarterly Long-Term Debt

Quarter Ending Long-Term Debt YoY QoQ
September 30, 2025 $93.40M -38.8% -2.4%
June 30, 2025 $95.70M -42.0% -2.3%
March 31, 2025 $98.00M -41.4% -21.8%
December 31, 2024 $125.30M -21.4% -17.9%
September 30, 2024 $152.60M -40.9% -7.5%
June 30, 2024 $164.90M -18.9% -1.4%
March 31, 2024 $167.20M -18.3% +4.9%
December 31, 2023 $159.40M -29.6% -38.3%
  • AVANOS MEDICAL, INC. showed a decrease of -27.9% in Long-Term Debt compared to the prior fiscal year.
  • The most recent figure is from AVANOS MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment